Results 171 to 180 of about 37,294 (214)

Somatostatin receptors 3 and 5 potentiate cholinergic-nerve-mediated contraction in human bronchus. [PDF]

Front Pharmacol
Brollo M, Grassin-Delyle S, Roquencourt C, Longchampt E, Miguet-Besson I, Glorion M, Salvator H, Devillier P.   +7 more
europepmc   +1 more source

The influence of somatostatin analogues on the incidence of pancreatic fistulas and postoperative morbidity in patients undergoing pancreatic resection: A Bayesian network meta-analysis. [PDF]

PLoS One
Hou Z, Hou S, Wang Z, Wang H, Deng M, Fan H.   +5 more
europepmc   +1 more source

Retraction: Synergistic antitumor activities of docetaxel and octreotide associated with apoptotic-upregulation in castration-resistant prostate cancer. [PDF]

PLoS One
PLOS One Editors.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Octreotide

Lancet, The, 1992
Z. Tulassay, L. Flautner, I. Fehérvári
exaly   +5 more sources

Octreotide and Octreotide-derived delivery systems

Journal of Drug Targeting, 2023
Pharmaceutical peptide Octreotide is a somatostatin analog with targeting and therapeutic abilities. Over the last decades, Octreotide has been developed and approved to treat acromegaly and neuroendocrine tumours, and Octreotide-based radioactive conjugates have been leveraged clinically to detect small neuroendocrine tumour sites.
Mingliang, Fan, Yue, Huang, Xinlin, Zhu, Jiayu, Zheng, Mingwei, Du   +4 more
openaire   +2 more sources

Octreotide

Reactions Weekly, 2023
  +4 more sources

Octreotide

Reactions Weekly, 2021
  +4 more sources

Octreotid

DMW - Deutsche Medizinische Wochenschrift, 2009
S. Herzig, H. Mönig
openaire   +1 more source

Octreotide

Reactions Weekly, 2022
openaire   +2 more sources

Octreotide

Reactions Weekly, 2012
  +4 more sources